热门资讯> 正文

Viatris获得Gwyn Lo避孕贴批准

2026-07-29 22:57

The US FDA has approved Viatris' (VTRS) Gwyn Lo (norelgestromin and ethinyl estradiol transdermal system) contraceptive patch.
Gwyn Lo is applied weekly for three consecutive weeks, and then one patch-free week.
Approval was based on the results from the phase 3 Luminous study.
The patch will become available later this year.

More on Viatris

Viatris Soared 54%: Time To Be More Careful (Rating Downgrade)
Viatris Inc. (VTRS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Viatris: From Cost Story To Pipeline-Driven Re-Rating (Rating Upgrade)
Merck signs licensing deals with companies including Viatris for new HIV pill
Viatris reports positive Japanese phase 3 results for Nefecon in IgAN

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。